Generation Bio is a biotechnology company that researches and develops gene therapies for the treatment of skeletal muscle diseases and eye disorders.
Business Model:
Revenue: $0
Employees: 51-200
Address: 301 Binney Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Generation Bio is a biotechnology company that researches and develops gene therapies for the treatment of skeletal muscle diseases and eye disorders.
Contact Phone:
+16176557500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/11/2020
IPO Valuation:
$848M
Ticker Symbol:
GBIO
IPO Price:
$19/share
Amount Raised:
$200M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | IPO | $199.5M |
|
2/2018 | Series B | 6 | $100M |
Casdin Capital Fidelity Management and Research Company Leerink Partners Invus Foresite Capital Deepfield Casdin Capital Fidelity Management and Research Company |
1/2018 | Series A | 1 | $25M |
Atlas Venture Atlas Venture |
1/2020 | Series C | 9 | $110M |
Foresite Capital T. Rowe Price Deerfield Wellington Management Farallon Capital Management Fidelity Invus Atlas Venture Casdin Capital T. Rowe Price Foresite Capital T. Rowe Price Deerfield Wellington Management Farallon Capital Management Fidelity Invus Atlas Venture Casdin Capital T. Rowe Price |
1/2021 | Post-IPO Equity | $225.4M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|